Senior insider sale
President & CEO at NEKTAR THERAPEUTICS — senior position signals high conviction
$1.23M
20.44K shares
What this filing means
ROBIN HOWARD W plans to sell 20.44K shares of NEKTAR THERAPEUTICS valued at approximately $1.23M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/17/2026ACC: 0001959173-26-004730
DirectorOfficer· President & CEO
Since Aug 2018
20.44K
Shares to sell
$1.23M
Approx. market value
10K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months5
Restricted Stock Vesting
Compensation
8/15/2024
1.28KRestricted Stock Vesting
Compensation
5/15/2024
1.87KRestricted Stock Vesting
Compensation
2/15/2023
2.27KRestricted Stock Vesting
Compensation
11/15/2022
2.08KRestricted Stock Vesting
Compensation
5/15/2022
2.49KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/15/2024 | Restricted Stock Vesting Compensation | 1.28K | — |
5/15/2024 | Restricted Stock Vesting Compensation | 1.87K | — |
2/15/2023 | Restricted Stock Vesting Compensation | 2.27K | — |
11/15/2022 | Restricted Stock Vesting Compensation | 2.08K | — |
5/15/2022 | Restricted Stock Vesting Compensation | 2.49K | — |
| Total | 10K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
10K
Market value
$603.1K
6/16/2026
—Completed
Units to sell
444.00
Market value
$29.1K
5/19/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
10K
Market value
$602.7K
6/17/2026
Total
Units
20.44K
Value
$1.23M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/16/2026 | 10K | $603.1K | — | Completed |
5/19/2026 | 444.00 | $29.1K | — | Completed |
| Planned — Approximate Date | ||||
6/17/2026 | 10K | $602.7K | NASDAQ | Planned |
| Total | 20.44K | $1.23M | ||